nodes	percent_of_prediction	percent_of_DWPC	metapath
Liotrix—THRB—breast cancer	0.239	0.554	CbGaD
Liotrix—SLCO1B1—breast cancer	0.14	0.325	CbGaD
Liotrix—SLCO1A2—Chlorambucil—breast cancer	0.0422	0.137	CbGbCtD
Liotrix—SLCO4C1—Methotrexate—breast cancer	0.0312	0.102	CbGbCtD
Liotrix—ALB—breast cancer	0.0266	0.0617	CbGaD
Liotrix—ABCB1—breast cancer	0.0254	0.0589	CbGaD
Liotrix—SLCO1B3—Paclitaxel—breast cancer	0.0235	0.0762	CbGbCtD
Liotrix—SLCO1C1—Methotrexate—breast cancer	0.0219	0.0713	CbGbCtD
Liotrix—SLCO1B3—Docetaxel—breast cancer	0.017	0.0551	CbGbCtD
Liotrix—CYP2C8—Lapatinib—breast cancer	0.0148	0.0482	CbGbCtD
Liotrix—ABCB1—Toremifene—breast cancer	0.0138	0.0447	CbGbCtD
Liotrix—SLCO1B1—Irinotecan—breast cancer	0.0135	0.0438	CbGbCtD
Liotrix—SLCO1B3—Methotrexate—breast cancer	0.0122	0.0398	CbGbCtD
Liotrix—CYP2C8—Raloxifene—breast cancer	0.0112	0.0365	CbGbCtD
Liotrix—ABCB1—Lapatinib—breast cancer	0.01	0.0326	CbGbCtD
Liotrix—SLCO1A2—Methotrexate—breast cancer	0.00756	0.0246	CbGbCtD
Liotrix—CYP2C8—Tamoxifen—breast cancer	0.00743	0.0241	CbGbCtD
Liotrix—ALB—Irinotecan—breast cancer	0.00738	0.024	CbGbCtD
Liotrix—SLCO1B1—Methotrexate—breast cancer	0.00713	0.0232	CbGbCtD
Liotrix—ALB—Fluorouracil—breast cancer	0.00708	0.023	CbGbCtD
Liotrix—SLC22A8—Methotrexate—breast cancer	0.00659	0.0214	CbGbCtD
Liotrix—CYP2C8—Paclitaxel—breast cancer	0.00578	0.0188	CbGbCtD
Liotrix—ABCB1—Vinorelbine—breast cancer	0.00557	0.0181	CbGbCtD
Liotrix—CYP2C8—Fluorouracil—breast cancer	0.00547	0.0178	CbGbCtD
Liotrix—ABCB1—Tamoxifen—breast cancer	0.00503	0.0163	CbGbCtD
Liotrix—ABCB1—Mitoxantrone—breast cancer	0.0049	0.0159	CbGbCtD
Liotrix—ABCB1—Gemcitabine—breast cancer	0.00433	0.0141	CbGbCtD
Liotrix—ABCB1—Paclitaxel—breast cancer	0.00391	0.0127	CbGbCtD
Liotrix—ALB—Methotrexate—breast cancer	0.00391	0.0127	CbGbCtD
Liotrix—ABCB1—Irinotecan—breast cancer	0.00386	0.0125	CbGbCtD
Liotrix—ABCB1—Vinblastine—breast cancer	0.00343	0.0112	CbGbCtD
Liotrix—ABCB1—Docetaxel—breast cancer	0.00283	0.0092	CbGbCtD
Liotrix—ABCB1—Doxorubicin—breast cancer	0.00211	0.00686	CbGbCtD
Liotrix—ABCB1—Methotrexate—breast cancer	0.00204	0.00664	CbGbCtD
Liotrix—THRB—mammary gland—breast cancer	0.00156	0.0404	CbGeAlD
Liotrix—SLCO4C1—nipple—breast cancer	0.00134	0.0349	CbGeAlD
Liotrix—Dextrothyroxine—THRB—breast cancer	0.00107	0.248	CrCbGaD
Liotrix—SLCO4A1—mammary gland—breast cancer	0.00104	0.0269	CbGeAlD
Liotrix—SERPINA7—bone marrow—breast cancer	0.000983	0.0255	CbGeAlD
Liotrix—SLCO1B1—mammary gland—breast cancer	0.000912	0.0237	CbGeAlD
Liotrix—SERPINA7—endocrine gland—breast cancer	0.000881	0.0229	CbGeAlD
Liotrix—SLCO4A1—nipple—breast cancer	0.000857	0.0223	CbGeAlD
Liotrix—SLCO4C1—endometrium—breast cancer	0.00081	0.021	CbGeAlD
Liotrix—Levothyroxine—THRB—breast cancer	0.00081	0.188	CrCbGaD
Liotrix—TTR—embryo—breast cancer	0.000789	0.0205	CbGeAlD
Liotrix—SLC16A10—nipple—breast cancer	0.000752	0.0195	CbGeAlD
Liotrix—ALB—mammary gland—breast cancer	0.000738	0.0192	CbGeAlD
Liotrix—SLCO1B3—pituitary gland—breast cancer	0.000713	0.0185	CbGeAlD
Liotrix—SLC16A2—endometrium—breast cancer	0.000704	0.0183	CbGeAlD
Liotrix—THRB—pituitary gland—breast cancer	0.000703	0.0183	CbGeAlD
Liotrix—THRA—adipose tissue—breast cancer	0.0007	0.0182	CbGeAlD
Liotrix—THRB—adipose tissue—breast cancer	0.0007	0.0182	CbGeAlD
Liotrix—SLC16A2—uterus—breast cancer	0.000649	0.0168	CbGeAlD
Liotrix—THRA—female reproductive system—breast cancer	0.000643	0.0167	CbGeAlD
Liotrix—THRB—female reproductive system—breast cancer	0.000643	0.0167	CbGeAlD
Liotrix—SLC16A2—pituitary gland—breast cancer	0.000637	0.0165	CbGeAlD
Liotrix—SLC16A2—adipose tissue—breast cancer	0.000634	0.0165	CbGeAlD
Liotrix—SLCO4C1—bone marrow—breast cancer	0.000634	0.0165	CbGeAlD
Liotrix—THRB—adrenal gland—breast cancer	0.000628	0.0163	CbGeAlD
Liotrix—THRA—adrenal gland—breast cancer	0.000628	0.0163	CbGeAlD
Liotrix—Dextrothyroxine—SLCO1B1—breast cancer	0.000627	0.146	CrCbGaD
Liotrix—THRA—female gonad—breast cancer	0.000586	0.0152	CbGeAlD
Liotrix—THRB—female gonad—breast cancer	0.000586	0.0152	CbGeAlD
Liotrix—SLCO1C1—pituitary gland—breast cancer	0.000584	0.0152	CbGeAlD
Liotrix—SLCO1C1—adipose tissue—breast cancer	0.000582	0.0151	CbGeAlD
Liotrix—Liothyronine—THRB—breast cancer	0.000577	0.134	CrCbGaD
Liotrix—SLC10A1—female reproductive system—breast cancer	0.000569	0.0148	CbGeAlD
Liotrix—SLC16A2—adrenal gland—breast cancer	0.000569	0.0148	CbGeAlD
Liotrix—SLCO1B3—endocrine gland—breast cancer	0.000552	0.0143	CbGeAlD
Liotrix—THRB—endocrine gland—breast cancer	0.000545	0.0141	CbGeAlD
Liotrix—THRA—endocrine gland—breast cancer	0.000545	0.0141	CbGeAlD
Liotrix—SLC16A2—female gonad—breast cancer	0.00053	0.0138	CbGeAlD
Liotrix—TTR—pituitary gland—breast cancer	0.000522	0.0136	CbGeAlD
Liotrix—CYP2C8—mammary gland—breast cancer	0.000518	0.0135	CbGeAlD
Liotrix—SLCO4A1—endometrium—breast cancer	0.000518	0.0134	CbGeAlD
Liotrix—SLC16A10—epithelium—breast cancer	0.000506	0.0131	CbGeAlD
Liotrix—SLC16A2—endocrine gland—breast cancer	0.000493	0.0128	CbGeAlD
Liotrix—SLC10A1—endocrine gland—breast cancer	0.000482	0.0125	CbGeAlD
Liotrix—TTR—female reproductive system—breast cancer	0.000478	0.0124	CbGeAlD
Liotrix—Levothyroxine—SLCO1B1—breast cancer	0.000475	0.11	CrCbGaD
Liotrix—SLCO4A1—pituitary gland—breast cancer	0.000468	0.0122	CbGeAlD
Liotrix—SLCO4A1—adipose tissue—breast cancer	0.000466	0.0121	CbGeAlD
Liotrix—SLCO1C1—endocrine gland—breast cancer	0.000453	0.0118	CbGeAlD
Liotrix—TTR—bone marrow—breast cancer	0.000452	0.0117	CbGeAlD
Liotrix—SLCO4A1—female reproductive system—breast cancer	0.000429	0.0111	CbGeAlD
Liotrix—SLCO4A1—adrenal gland—breast cancer	0.000418	0.0109	CbGeAlD
Liotrix—SLC16A10—adipose tissue—breast cancer	0.000409	0.0106	CbGeAlD
Liotrix—TTR—endocrine gland—breast cancer	0.000405	0.0105	CbGeAlD
Liotrix—SLCO1B1—female reproductive system—breast cancer	0.000377	0.0098	CbGeAlD
Liotrix—THRB—lymph node—breast cancer	0.000376	0.00978	CbGeAlD
Liotrix—THRA—lymph node—breast cancer	0.000376	0.00978	CbGeAlD
Liotrix—SLC16A10—female reproductive system—breast cancer	0.000376	0.00976	CbGeAlD
Liotrix—SLCO4A1—endocrine gland—breast cancer	0.000363	0.00942	CbGeAlD
Liotrix—SLC16A2—lymph node—breast cancer	0.000341	0.00886	CbGeAlD
Liotrix—Liothyronine—SLCO1B1—breast cancer	0.000338	0.0787	CrCbGaD
Liotrix—SLCO1B1—endocrine gland—breast cancer	0.000319	0.00829	CbGeAlD
Liotrix—SLC16A10—endocrine gland—breast cancer	0.000318	0.00826	CbGeAlD
Liotrix—SLCO1C1—lymph node—breast cancer	0.000313	0.00813	CbGeAlD
Liotrix—ALB—adrenal gland—breast cancer	0.000298	0.00774	CbGeAlD
Liotrix—SLCO1A2—endocrine gland—breast cancer	0.00026	0.00675	CbGeAlD
Liotrix—CYP2C8—endometrium—breast cancer	0.000259	0.00673	CbGeAlD
Liotrix—SLCO4A1—lymph node—breast cancer	0.000251	0.00651	CbGeAlD
Liotrix—CYP2C8—pituitary gland—breast cancer	0.000234	0.00609	CbGeAlD
Liotrix—SLC16A10—lymph node—breast cancer	0.00022	0.00571	CbGeAlD
Liotrix—CYP2C8—female reproductive system—breast cancer	0.000215	0.00557	CbGeAlD
Liotrix—CYP2C8—endocrine gland—breast cancer	0.000182	0.00471	CbGeAlD
Liotrix—ALB—lymph node—breast cancer	0.000179	0.00464	CbGeAlD
Liotrix—ABCB1—embryo—breast cancer	0.00017	0.00441	CbGeAlD
Liotrix—ABCB1—epithelium—breast cancer	0.000138	0.0036	CbGeAlD
Liotrix—ABCB1—endometrium—breast cancer	0.000124	0.00322	CbGeAlD
Liotrix—ABCB1—uterus—breast cancer	0.000114	0.00297	CbGeAlD
Liotrix—ABCB1—pituitary gland—breast cancer	0.000112	0.00292	CbGeAlD
Liotrix—ABCB1—adipose tissue—breast cancer	0.000112	0.00291	CbGeAlD
Liotrix—Levothyroxine—CYP3A4—breast cancer	0.000103	0.024	CrCbGaD
Liotrix—ABCB1—female reproductive system—breast cancer	0.000103	0.00267	CbGeAlD
Liotrix—ABCB1—adrenal gland—breast cancer	0.0001	0.00261	CbGeAlD
Liotrix—ABCB1—bone marrow—breast cancer	9.71e-05	0.00252	CbGeAlD
Liotrix—ABCB1—female gonad—breast cancer	9.36e-05	0.00243	CbGeAlD
Liotrix—Levothyroxine—ALB—breast cancer	9.02e-05	0.021	CrCbGaD
Liotrix—ABCB1—endocrine gland—breast cancer	8.7e-05	0.00226	CbGeAlD
Liotrix—Levothyroxine—ABCB1—breast cancer	8.6e-05	0.02	CrCbGaD
Liotrix—Liothyronine—ALB—breast cancer	6.42e-05	0.0149	CrCbGaD
Liotrix—Liothyronine—ABCB1—breast cancer	6.13e-05	0.0143	CrCbGaD
Liotrix—ABCB1—lymph node—breast cancer	6.02e-05	0.00156	CbGeAlD
Liotrix—Renal failure—Epirubicin—breast cancer	3.87e-05	0.000311	CcSEcCtD
Liotrix—Asthenia—Irinotecan—breast cancer	3.86e-05	0.00031	CcSEcCtD
Liotrix—Asthenia—Mitoxantrone—breast cancer	3.86e-05	0.00031	CcSEcCtD
Liotrix—Decreased appetite—Paclitaxel—breast cancer	3.81e-05	0.000307	CcSEcCtD
Liotrix—Hypertension—Capecitabine—breast cancer	3.81e-05	0.000306	CcSEcCtD
Liotrix—Hypersensitivity—Fluorouracil—breast cancer	3.8e-05	0.000305	CcSEcCtD
Liotrix—Fatigue—Paclitaxel—breast cancer	3.78e-05	0.000304	CcSEcCtD
Liotrix—Sweating—Epirubicin—breast cancer	3.77e-05	0.000303	CcSEcCtD
Liotrix—Asthenia—Gemcitabine—breast cancer	3.76e-05	0.000302	CcSEcCtD
Liotrix—Arthralgia—Capecitabine—breast cancer	3.76e-05	0.000302	CcSEcCtD
Liotrix—Chest pain—Capecitabine—breast cancer	3.76e-05	0.000302	CcSEcCtD
Liotrix—Constipation—Paclitaxel—breast cancer	3.75e-05	0.000302	CcSEcCtD
Liotrix—Confusional state—Docetaxel—breast cancer	3.75e-05	0.000301	CcSEcCtD
Liotrix—Anxiety—Capecitabine—breast cancer	3.74e-05	0.000301	CcSEcCtD
Liotrix—Anaphylactic shock—Docetaxel—breast cancer	3.72e-05	0.000299	CcSEcCtD
Liotrix—Oedema—Docetaxel—breast cancer	3.72e-05	0.000299	CcSEcCtD
Liotrix—Pruritus—Gemcitabine—breast cancer	3.71e-05	0.000298	CcSEcCtD
Liotrix—Nausea—Thiotepa—breast cancer	3.7e-05	0.000297	CcSEcCtD
Liotrix—Infection—Docetaxel—breast cancer	3.69e-05	0.000297	CcSEcCtD
Liotrix—Weight decreased—Doxorubicin—breast cancer	3.69e-05	0.000297	CcSEcCtD
Liotrix—Diarrhoea—Mitoxantrone—breast cancer	3.68e-05	0.000296	CcSEcCtD
Liotrix—Diarrhoea—Irinotecan—breast cancer	3.68e-05	0.000296	CcSEcCtD
Liotrix—Shock—Docetaxel—breast cancer	3.66e-05	0.000294	CcSEcCtD
Liotrix—Pruritus—Fluorouracil—breast cancer	3.64e-05	0.000293	CcSEcCtD
Liotrix—Confusional state—Capecitabine—breast cancer	3.63e-05	0.000292	CcSEcCtD
Liotrix—Tachycardia—Docetaxel—breast cancer	3.63e-05	0.000292	CcSEcCtD
Liotrix—Feeling abnormal—Paclitaxel—breast cancer	3.61e-05	0.000291	CcSEcCtD
Liotrix—Oedema—Capecitabine—breast cancer	3.6e-05	0.000289	CcSEcCtD
Liotrix—Gastrointestinal pain—Paclitaxel—breast cancer	3.59e-05	0.000288	CcSEcCtD
Liotrix—Diarrhoea—Gemcitabine—breast cancer	3.58e-05	0.000288	CcSEcCtD
Liotrix—Renal failure—Doxorubicin—breast cancer	3.58e-05	0.000288	CcSEcCtD
Liotrix—Infection—Capecitabine—breast cancer	3.58e-05	0.000288	CcSEcCtD
Liotrix—Dizziness—Irinotecan—breast cancer	3.56e-05	0.000286	CcSEcCtD
Liotrix—Anorexia—Docetaxel—breast cancer	3.54e-05	0.000285	CcSEcCtD
Liotrix—Shock—Capecitabine—breast cancer	3.54e-05	0.000285	CcSEcCtD
Liotrix—Diarrhoea—Fluorouracil—breast cancer	3.52e-05	0.000283	CcSEcCtD
Liotrix—Tachycardia—Capecitabine—breast cancer	3.51e-05	0.000283	CcSEcCtD
Liotrix—Hypoaesthesia—Epirubicin—breast cancer	3.51e-05	0.000282	CcSEcCtD
Liotrix—Sweating—Doxorubicin—breast cancer	3.49e-05	0.00028	CcSEcCtD
Liotrix—Urticaria—Paclitaxel—breast cancer	3.48e-05	0.00028	CcSEcCtD
Liotrix—Hyperhidrosis—Capecitabine—breast cancer	3.48e-05	0.00028	CcSEcCtD
Liotrix—Hypotension—Docetaxel—breast cancer	3.47e-05	0.000279	CcSEcCtD
Liotrix—Abdominal pain—Paclitaxel—breast cancer	3.47e-05	0.000279	CcSEcCtD
Liotrix—Body temperature increased—Paclitaxel—breast cancer	3.47e-05	0.000279	CcSEcCtD
Liotrix—Anorexia—Capecitabine—breast cancer	3.43e-05	0.000276	CcSEcCtD
Liotrix—Vomiting—Irinotecan—breast cancer	3.42e-05	0.000275	CcSEcCtD
Liotrix—Vomiting—Mitoxantrone—breast cancer	3.42e-05	0.000275	CcSEcCtD
Liotrix—Dizziness—Fluorouracil—breast cancer	3.41e-05	0.000274	CcSEcCtD
Liotrix—Rash—Mitoxantrone—breast cancer	3.39e-05	0.000273	CcSEcCtD
Liotrix—Rash—Irinotecan—breast cancer	3.39e-05	0.000273	CcSEcCtD
Liotrix—Dermatitis—Irinotecan—breast cancer	3.39e-05	0.000272	CcSEcCtD
Liotrix—Dermatitis—Mitoxantrone—breast cancer	3.39e-05	0.000272	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Docetaxel—breast cancer	3.39e-05	0.000272	CcSEcCtD
Liotrix—Headache—Mitoxantrone—breast cancer	3.37e-05	0.000271	CcSEcCtD
Liotrix—Headache—Irinotecan—breast cancer	3.37e-05	0.000271	CcSEcCtD
Liotrix—Hypotension—Capecitabine—breast cancer	3.36e-05	0.00027	CcSEcCtD
Liotrix—Insomnia—Docetaxel—breast cancer	3.36e-05	0.00027	CcSEcCtD
Liotrix—Paraesthesia—Docetaxel—breast cancer	3.34e-05	0.000268	CcSEcCtD
Liotrix—Alopecia—Methotrexate—breast cancer	3.33e-05	0.000268	CcSEcCtD
Liotrix—Vomiting—Gemcitabine—breast cancer	3.33e-05	0.000268	CcSEcCtD
Liotrix—Dyspnoea—Docetaxel—breast cancer	3.31e-05	0.000267	CcSEcCtD
Liotrix—Rash—Gemcitabine—breast cancer	3.3e-05	0.000266	CcSEcCtD
Liotrix—Dermatitis—Gemcitabine—breast cancer	3.3e-05	0.000265	CcSEcCtD
Liotrix—Headache—Gemcitabine—breast cancer	3.28e-05	0.000264	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Capecitabine—breast cancer	3.28e-05	0.000264	CcSEcCtD
Liotrix—Flushing—Epirubicin—breast cancer	3.28e-05	0.000263	CcSEcCtD
Liotrix—Vomiting—Fluorouracil—breast cancer	3.28e-05	0.000263	CcSEcCtD
Liotrix—Insomnia—Capecitabine—breast cancer	3.26e-05	0.000262	CcSEcCtD
Liotrix—Hypoaesthesia—Doxorubicin—breast cancer	3.25e-05	0.000261	CcSEcCtD
Liotrix—Rash—Fluorouracil—breast cancer	3.25e-05	0.000261	CcSEcCtD
Liotrix—Dermatitis—Fluorouracil—breast cancer	3.25e-05	0.000261	CcSEcCtD
Liotrix—Paraesthesia—Capecitabine—breast cancer	3.23e-05	0.00026	CcSEcCtD
Liotrix—Decreased appetite—Docetaxel—breast cancer	3.23e-05	0.00026	CcSEcCtD
Liotrix—Hypersensitivity—Paclitaxel—breast cancer	3.23e-05	0.00026	CcSEcCtD
Liotrix—Headache—Fluorouracil—breast cancer	3.23e-05	0.000259	CcSEcCtD
Liotrix—Dysgeusia—Methotrexate—breast cancer	3.22e-05	0.000259	CcSEcCtD
Liotrix—Dyspnoea—Capecitabine—breast cancer	3.21e-05	0.000258	CcSEcCtD
Liotrix—Fatigue—Docetaxel—breast cancer	3.21e-05	0.000258	CcSEcCtD
Liotrix—Nausea—Mitoxantrone—breast cancer	3.19e-05	0.000257	CcSEcCtD
Liotrix—Nausea—Irinotecan—breast cancer	3.19e-05	0.000257	CcSEcCtD
Liotrix—Constipation—Docetaxel—breast cancer	3.18e-05	0.000256	CcSEcCtD
Liotrix—Arrhythmia—Epirubicin—breast cancer	3.15e-05	0.000254	CcSEcCtD
Liotrix—Asthenia—Paclitaxel—breast cancer	3.15e-05	0.000253	CcSEcCtD
Liotrix—Decreased appetite—Capecitabine—breast cancer	3.13e-05	0.000252	CcSEcCtD
Liotrix—Alopecia—Epirubicin—breast cancer	3.12e-05	0.000251	CcSEcCtD
Liotrix—Nausea—Gemcitabine—breast cancer	3.11e-05	0.00025	CcSEcCtD
Liotrix—Fatigue—Capecitabine—breast cancer	3.1e-05	0.00025	CcSEcCtD
Liotrix—Pruritus—Paclitaxel—breast cancer	3.1e-05	0.00025	CcSEcCtD
Liotrix—Vision blurred—Methotrexate—breast cancer	3.09e-05	0.000249	CcSEcCtD
Liotrix—Constipation—Capecitabine—breast cancer	3.08e-05	0.000248	CcSEcCtD
Liotrix—Feeling abnormal—Docetaxel—breast cancer	3.06e-05	0.000246	CcSEcCtD
Liotrix—Nausea—Fluorouracil—breast cancer	3.06e-05	0.000246	CcSEcCtD
Liotrix—Gastrointestinal pain—Docetaxel—breast cancer	3.04e-05	0.000244	CcSEcCtD
Liotrix—Flushing—Doxorubicin—breast cancer	3.03e-05	0.000244	CcSEcCtD
Liotrix—Flatulence—Epirubicin—breast cancer	3.03e-05	0.000243	CcSEcCtD
Liotrix—Tension—Epirubicin—breast cancer	3.02e-05	0.000242	CcSEcCtD
Liotrix—Dysgeusia—Epirubicin—breast cancer	3.01e-05	0.000242	CcSEcCtD
Liotrix—Diarrhoea—Paclitaxel—breast cancer	3e-05	0.000241	CcSEcCtD
Liotrix—Nervousness—Epirubicin—breast cancer	2.98e-05	0.00024	CcSEcCtD
Liotrix—Feeling abnormal—Capecitabine—breast cancer	2.97e-05	0.000239	CcSEcCtD
Liotrix—Gastrointestinal pain—Capecitabine—breast cancer	2.94e-05	0.000237	CcSEcCtD
Liotrix—Body temperature increased—Docetaxel—breast cancer	2.94e-05	0.000236	CcSEcCtD
Liotrix—Abdominal pain—Docetaxel—breast cancer	2.94e-05	0.000236	CcSEcCtD
Liotrix—Arrhythmia—Doxorubicin—breast cancer	2.92e-05	0.000235	CcSEcCtD
Liotrix—Dizziness—Paclitaxel—breast cancer	2.9e-05	0.000233	CcSEcCtD
Liotrix—Vision blurred—Epirubicin—breast cancer	2.9e-05	0.000233	CcSEcCtD
Liotrix—Alopecia—Doxorubicin—breast cancer	2.89e-05	0.000232	CcSEcCtD
Liotrix—Urticaria—Capecitabine—breast cancer	2.86e-05	0.00023	CcSEcCtD
Liotrix—Abdominal pain—Capecitabine—breast cancer	2.85e-05	0.000229	CcSEcCtD
Liotrix—Body temperature increased—Capecitabine—breast cancer	2.85e-05	0.000229	CcSEcCtD
Liotrix—Convulsion—Methotrexate—breast cancer	2.84e-05	0.000229	CcSEcCtD
Liotrix—Agitation—Epirubicin—breast cancer	2.82e-05	0.000227	CcSEcCtD
Liotrix—Flatulence—Doxorubicin—breast cancer	2.8e-05	0.000225	CcSEcCtD
Liotrix—Arthralgia—Methotrexate—breast cancer	2.8e-05	0.000225	CcSEcCtD
Liotrix—Chest pain—Methotrexate—breast cancer	2.8e-05	0.000225	CcSEcCtD
Liotrix—Tension—Doxorubicin—breast cancer	2.79e-05	0.000224	CcSEcCtD
Liotrix—Vomiting—Paclitaxel—breast cancer	2.79e-05	0.000224	CcSEcCtD
Liotrix—Dysgeusia—Doxorubicin—breast cancer	2.78e-05	0.000224	CcSEcCtD
Liotrix—Rash—Paclitaxel—breast cancer	2.77e-05	0.000222	CcSEcCtD
Liotrix—Dermatitis—Paclitaxel—breast cancer	2.76e-05	0.000222	CcSEcCtD
Liotrix—Nervousness—Doxorubicin—breast cancer	2.76e-05	0.000222	CcSEcCtD
Liotrix—Syncope—Epirubicin—breast cancer	2.76e-05	0.000222	CcSEcCtD
Liotrix—Headache—Paclitaxel—breast cancer	2.75e-05	0.000221	CcSEcCtD
Liotrix—Hypersensitivity—Docetaxel—breast cancer	2.74e-05	0.00022	CcSEcCtD
Liotrix—Palpitations—Epirubicin—breast cancer	2.72e-05	0.000218	CcSEcCtD
Liotrix—Confusional state—Methotrexate—breast cancer	2.7e-05	0.000217	CcSEcCtD
Liotrix—Loss of consciousness—Epirubicin—breast cancer	2.7e-05	0.000217	CcSEcCtD
Liotrix—Anaphylactic shock—Methotrexate—breast cancer	2.68e-05	0.000215	CcSEcCtD
Liotrix—Vision blurred—Doxorubicin—breast cancer	2.68e-05	0.000215	CcSEcCtD
Liotrix—Asthenia—Docetaxel—breast cancer	2.67e-05	0.000215	CcSEcCtD
Liotrix—Convulsion—Epirubicin—breast cancer	2.66e-05	0.000214	CcSEcCtD
Liotrix—Infection—Methotrexate—breast cancer	2.66e-05	0.000214	CcSEcCtD
Liotrix—Hypertension—Epirubicin—breast cancer	2.65e-05	0.000213	CcSEcCtD
Liotrix—Hypersensitivity—Capecitabine—breast cancer	2.65e-05	0.000213	CcSEcCtD
Liotrix—Pruritus—Docetaxel—breast cancer	2.63e-05	0.000212	CcSEcCtD
Liotrix—Arthralgia—Epirubicin—breast cancer	2.62e-05	0.00021	CcSEcCtD
Liotrix—Chest pain—Epirubicin—breast cancer	2.62e-05	0.00021	CcSEcCtD
Liotrix—Agitation—Doxorubicin—breast cancer	2.61e-05	0.00021	CcSEcCtD
Liotrix—Anxiety—Epirubicin—breast cancer	2.61e-05	0.00021	CcSEcCtD
Liotrix—Nausea—Paclitaxel—breast cancer	2.61e-05	0.00021	CcSEcCtD
Liotrix—Hyperhidrosis—Methotrexate—breast cancer	2.59e-05	0.000208	CcSEcCtD
Liotrix—Asthenia—Capecitabine—breast cancer	2.58e-05	0.000208	CcSEcCtD
Liotrix—Anorexia—Methotrexate—breast cancer	2.55e-05	0.000205	CcSEcCtD
Liotrix—Syncope—Doxorubicin—breast cancer	2.55e-05	0.000205	CcSEcCtD
Liotrix—Pruritus—Capecitabine—breast cancer	2.55e-05	0.000205	CcSEcCtD
Liotrix—Diarrhoea—Docetaxel—breast cancer	2.54e-05	0.000205	CcSEcCtD
Liotrix—Confusional state—Epirubicin—breast cancer	2.53e-05	0.000203	CcSEcCtD
Liotrix—Palpitations—Doxorubicin—breast cancer	2.51e-05	0.000202	CcSEcCtD
Liotrix—Oedema—Epirubicin—breast cancer	2.51e-05	0.000202	CcSEcCtD
Liotrix—Anaphylactic shock—Epirubicin—breast cancer	2.51e-05	0.000202	CcSEcCtD
Liotrix—Hypotension—Methotrexate—breast cancer	2.5e-05	0.000201	CcSEcCtD
Liotrix—Loss of consciousness—Doxorubicin—breast cancer	2.5e-05	0.000201	CcSEcCtD
Liotrix—Infection—Epirubicin—breast cancer	2.49e-05	0.0002	CcSEcCtD
Liotrix—Shock—Epirubicin—breast cancer	2.47e-05	0.000198	CcSEcCtD
Liotrix—Convulsion—Doxorubicin—breast cancer	2.46e-05	0.000198	CcSEcCtD
Liotrix—Diarrhoea—Capecitabine—breast cancer	2.46e-05	0.000198	CcSEcCtD
Liotrix—Dizziness—Docetaxel—breast cancer	2.46e-05	0.000198	CcSEcCtD
Liotrix—Hypertension—Doxorubicin—breast cancer	2.45e-05	0.000197	CcSEcCtD
Liotrix—Tachycardia—Epirubicin—breast cancer	2.45e-05	0.000197	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Methotrexate—breast cancer	2.44e-05	0.000196	CcSEcCtD
Liotrix—Hyperhidrosis—Epirubicin—breast cancer	2.42e-05	0.000195	CcSEcCtD
Liotrix—Insomnia—Methotrexate—breast cancer	2.42e-05	0.000195	CcSEcCtD
Liotrix—Arthralgia—Doxorubicin—breast cancer	2.42e-05	0.000195	CcSEcCtD
Liotrix—Chest pain—Doxorubicin—breast cancer	2.42e-05	0.000195	CcSEcCtD
Liotrix—Anxiety—Doxorubicin—breast cancer	2.41e-05	0.000194	CcSEcCtD
Liotrix—Paraesthesia—Methotrexate—breast cancer	2.41e-05	0.000193	CcSEcCtD
Liotrix—Anorexia—Epirubicin—breast cancer	2.39e-05	0.000192	CcSEcCtD
Liotrix—Dyspnoea—Methotrexate—breast cancer	2.39e-05	0.000192	CcSEcCtD
Liotrix—Dizziness—Capecitabine—breast cancer	2.38e-05	0.000191	CcSEcCtD
Liotrix—Vomiting—Docetaxel—breast cancer	2.36e-05	0.00019	CcSEcCtD
Liotrix—Rash—Docetaxel—breast cancer	2.34e-05	0.000189	CcSEcCtD
Liotrix—Hypotension—Epirubicin—breast cancer	2.34e-05	0.000188	CcSEcCtD
Liotrix—Dermatitis—Docetaxel—breast cancer	2.34e-05	0.000188	CcSEcCtD
Liotrix—Confusional state—Doxorubicin—breast cancer	2.34e-05	0.000188	CcSEcCtD
Liotrix—Decreased appetite—Methotrexate—breast cancer	2.33e-05	0.000187	CcSEcCtD
Liotrix—Headache—Docetaxel—breast cancer	2.33e-05	0.000187	CcSEcCtD
Liotrix—Anaphylactic shock—Doxorubicin—breast cancer	2.32e-05	0.000187	CcSEcCtD
Liotrix—Oedema—Doxorubicin—breast cancer	2.32e-05	0.000187	CcSEcCtD
Liotrix—Fatigue—Methotrexate—breast cancer	2.31e-05	0.000186	CcSEcCtD
Liotrix—Infection—Doxorubicin—breast cancer	2.31e-05	0.000185	CcSEcCtD
Liotrix—Vomiting—Capecitabine—breast cancer	2.29e-05	0.000184	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Epirubicin—breast cancer	2.28e-05	0.000184	CcSEcCtD
Liotrix—Shock—Doxorubicin—breast cancer	2.28e-05	0.000184	CcSEcCtD
Liotrix—Rash—Capecitabine—breast cancer	2.27e-05	0.000183	CcSEcCtD
Liotrix—Insomnia—Epirubicin—breast cancer	2.27e-05	0.000182	CcSEcCtD
Liotrix—Dermatitis—Capecitabine—breast cancer	2.27e-05	0.000182	CcSEcCtD
Liotrix—Tachycardia—Doxorubicin—breast cancer	2.26e-05	0.000182	CcSEcCtD
Liotrix—Headache—Capecitabine—breast cancer	2.26e-05	0.000181	CcSEcCtD
Liotrix—Paraesthesia—Epirubicin—breast cancer	2.25e-05	0.000181	CcSEcCtD
Liotrix—Hyperhidrosis—Doxorubicin—breast cancer	2.24e-05	0.00018	CcSEcCtD
Liotrix—Dyspnoea—Epirubicin—breast cancer	2.24e-05	0.00018	CcSEcCtD
Liotrix—Anorexia—Doxorubicin—breast cancer	2.21e-05	0.000178	CcSEcCtD
Liotrix—Nausea—Docetaxel—breast cancer	2.21e-05	0.000178	CcSEcCtD
Liotrix—Feeling abnormal—Methotrexate—breast cancer	2.21e-05	0.000178	CcSEcCtD
Liotrix—Gastrointestinal pain—Methotrexate—breast cancer	2.19e-05	0.000176	CcSEcCtD
Liotrix—Decreased appetite—Epirubicin—breast cancer	2.18e-05	0.000175	CcSEcCtD
Liotrix—Hypotension—Doxorubicin—breast cancer	2.17e-05	0.000174	CcSEcCtD
Liotrix—Fatigue—Epirubicin—breast cancer	2.16e-05	0.000174	CcSEcCtD
Liotrix—Constipation—Epirubicin—breast cancer	2.14e-05	0.000172	CcSEcCtD
Liotrix—Nausea—Capecitabine—breast cancer	2.14e-05	0.000172	CcSEcCtD
Liotrix—Urticaria—Methotrexate—breast cancer	2.13e-05	0.000171	CcSEcCtD
Liotrix—Body temperature increased—Methotrexate—breast cancer	2.12e-05	0.00017	CcSEcCtD
Liotrix—Abdominal pain—Methotrexate—breast cancer	2.12e-05	0.00017	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.11e-05	0.00017	CcSEcCtD
Liotrix—Insomnia—Doxorubicin—breast cancer	2.1e-05	0.000169	CcSEcCtD
Liotrix—Paraesthesia—Doxorubicin—breast cancer	2.08e-05	0.000168	CcSEcCtD
Liotrix—Dyspnoea—Doxorubicin—breast cancer	2.07e-05	0.000166	CcSEcCtD
Liotrix—Feeling abnormal—Epirubicin—breast cancer	2.07e-05	0.000166	CcSEcCtD
Liotrix—Gastrointestinal pain—Epirubicin—breast cancer	2.05e-05	0.000165	CcSEcCtD
Liotrix—Decreased appetite—Doxorubicin—breast cancer	2.02e-05	0.000162	CcSEcCtD
Liotrix—Fatigue—Doxorubicin—breast cancer	2e-05	0.000161	CcSEcCtD
Liotrix—Urticaria—Epirubicin—breast cancer	1.99e-05	0.00016	CcSEcCtD
Liotrix—Constipation—Doxorubicin—breast cancer	1.98e-05	0.00016	CcSEcCtD
Liotrix—Body temperature increased—Epirubicin—breast cancer	1.98e-05	0.000159	CcSEcCtD
Liotrix—Abdominal pain—Epirubicin—breast cancer	1.98e-05	0.000159	CcSEcCtD
Liotrix—Hypersensitivity—Methotrexate—breast cancer	1.97e-05	0.000159	CcSEcCtD
Liotrix—Asthenia—Methotrexate—breast cancer	1.92e-05	0.000155	CcSEcCtD
Liotrix—Feeling abnormal—Doxorubicin—breast cancer	1.91e-05	0.000154	CcSEcCtD
Liotrix—Gastrointestinal pain—Doxorubicin—breast cancer	1.9e-05	0.000153	CcSEcCtD
Liotrix—Pruritus—Methotrexate—breast cancer	1.9e-05	0.000152	CcSEcCtD
Liotrix—Hypersensitivity—Epirubicin—breast cancer	1.85e-05	0.000149	CcSEcCtD
Liotrix—Urticaria—Doxorubicin—breast cancer	1.84e-05	0.000148	CcSEcCtD
Liotrix—Body temperature increased—Doxorubicin—breast cancer	1.83e-05	0.000147	CcSEcCtD
Liotrix—Abdominal pain—Doxorubicin—breast cancer	1.83e-05	0.000147	CcSEcCtD
Liotrix—Diarrhoea—Methotrexate—breast cancer	1.83e-05	0.000147	CcSEcCtD
Liotrix—Asthenia—Epirubicin—breast cancer	1.8e-05	0.000145	CcSEcCtD
Liotrix—Pruritus—Epirubicin—breast cancer	1.77e-05	0.000143	CcSEcCtD
Liotrix—Dizziness—Methotrexate—breast cancer	1.77e-05	0.000142	CcSEcCtD
Liotrix—Diarrhoea—Epirubicin—breast cancer	1.72e-05	0.000138	CcSEcCtD
Liotrix—Hypersensitivity—Doxorubicin—breast cancer	1.71e-05	0.000137	CcSEcCtD
Liotrix—Vomiting—Methotrexate—breast cancer	1.7e-05	0.000137	CcSEcCtD
Liotrix—Rash—Methotrexate—breast cancer	1.69e-05	0.000136	CcSEcCtD
Liotrix—Dermatitis—Methotrexate—breast cancer	1.69e-05	0.000136	CcSEcCtD
Liotrix—Headache—Methotrexate—breast cancer	1.68e-05	0.000135	CcSEcCtD
Liotrix—Asthenia—Doxorubicin—breast cancer	1.66e-05	0.000134	CcSEcCtD
Liotrix—Dizziness—Epirubicin—breast cancer	1.66e-05	0.000133	CcSEcCtD
Liotrix—Pruritus—Doxorubicin—breast cancer	1.64e-05	0.000132	CcSEcCtD
Liotrix—Vomiting—Epirubicin—breast cancer	1.59e-05	0.000128	CcSEcCtD
Liotrix—Nausea—Methotrexate—breast cancer	1.59e-05	0.000128	CcSEcCtD
Liotrix—Diarrhoea—Doxorubicin—breast cancer	1.59e-05	0.000128	CcSEcCtD
Liotrix—Rash—Epirubicin—breast cancer	1.58e-05	0.000127	CcSEcCtD
Liotrix—Dermatitis—Epirubicin—breast cancer	1.58e-05	0.000127	CcSEcCtD
Liotrix—Headache—Epirubicin—breast cancer	1.57e-05	0.000126	CcSEcCtD
Liotrix—Dizziness—Doxorubicin—breast cancer	1.53e-05	0.000123	CcSEcCtD
Liotrix—Nausea—Epirubicin—breast cancer	1.49e-05	0.00012	CcSEcCtD
Liotrix—Vomiting—Doxorubicin—breast cancer	1.48e-05	0.000119	CcSEcCtD
Liotrix—Rash—Doxorubicin—breast cancer	1.46e-05	0.000118	CcSEcCtD
Liotrix—Dermatitis—Doxorubicin—breast cancer	1.46e-05	0.000118	CcSEcCtD
Liotrix—Headache—Doxorubicin—breast cancer	1.45e-05	0.000117	CcSEcCtD
Liotrix—Nausea—Doxorubicin—breast cancer	1.38e-05	0.000111	CcSEcCtD
Liotrix—ALB—Metabolism—MED12—breast cancer	2.98e-06	3.19e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—DPYD—breast cancer	2.98e-06	3.19e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CTNNB1—breast cancer	2.98e-06	3.19e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—NAT2—breast cancer	2.98e-06	3.19e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—TYMS—breast cancer	2.98e-06	3.18e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ALDOA—breast cancer	2.95e-06	3.16e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—NCOR1—breast cancer	2.94e-06	3.15e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PLA2G4A—breast cancer	2.94e-06	3.15e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—GSTM1—breast cancer	2.94e-06	3.15e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—ALDOA—breast cancer	2.94e-06	3.14e-05	CbGpPWpGaD
Liotrix—TTR—Disease—PIK3CA—breast cancer	2.93e-06	3.13e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MMP9—breast cancer	2.92e-06	3.13e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CDKN1A—breast cancer	2.91e-06	3.12e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—PTEN—breast cancer	2.91e-06	3.11e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—NCOA3—breast cancer	2.87e-06	3.07e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PIK3CD—breast cancer	2.86e-06	3.06e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—NCOA3—breast cancer	2.85e-06	3.05e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—SLC2A2—breast cancer	2.85e-06	3.05e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MAPK8—breast cancer	2.84e-06	3.04e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—SLC2A2—breast cancer	2.83e-06	3.03e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—ALB—breast cancer	2.82e-06	3.02e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	2.82e-06	3.01e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—IGF1—breast cancer	2.82e-06	3.01e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—GPX1—breast cancer	2.82e-06	3.01e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—AKT2—breast cancer	2.82e-06	3.01e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—CAV1—breast cancer	2.8e-06	3e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	2.8e-06	3e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ABCG2—breast cancer	2.79e-06	2.98e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CPT1A—breast cancer	2.79e-06	2.98e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—MTR—breast cancer	2.79e-06	2.98e-05	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—PIK3CA—breast cancer	2.79e-06	2.98e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—CYP1A1—breast cancer	2.79e-06	2.98e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CPT1A—breast cancer	2.77e-06	2.97e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—MTR—breast cancer	2.77e-06	2.97e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—ABCG2—breast cancer	2.77e-06	2.97e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—ERCC2—breast cancer	2.77e-06	2.96e-05	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—breast cancer	2.75e-06	2.94e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—HPGDS—breast cancer	2.74e-06	2.93e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—HPGDS—breast cancer	2.72e-06	2.91e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—HBA1—breast cancer	2.72e-06	2.91e-05	CbGpPWpGaD
Liotrix—TTR—Disease—HRAS—breast cancer	2.71e-06	2.9e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PIK3CD—breast cancer	2.71e-06	2.89e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—HBA1—breast cancer	2.7e-06	2.89e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—NOS3—breast cancer	2.7e-06	2.89e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—SRC—breast cancer	2.7e-06	2.88e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.68e-06	2.87e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—SERPINE1—breast cancer	2.68e-06	2.86e-05	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—breast cancer	2.66e-06	2.84e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ACHE—breast cancer	2.65e-06	2.84e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GSTT1—breast cancer	2.65e-06	2.84e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—ACHE—breast cancer	2.64e-06	2.82e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—GSTT1—breast cancer	2.64e-06	2.82e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—VEGFA—breast cancer	2.62e-06	2.81e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—MED12—breast cancer	2.61e-06	2.8e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—DPYD—breast cancer	2.61e-06	2.8e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—MTHFR—breast cancer	2.6e-06	2.78e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—STAT3—breast cancer	2.6e-06	2.78e-05	CbGpPWpGaD
Liotrix—TTR—Disease—IL6—breast cancer	2.59e-06	2.77e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ALDOA—breast cancer	2.57e-06	2.75e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—NOS3—breast cancer	2.55e-06	2.73e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PIK3CG—breast cancer	2.55e-06	2.73e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CYP17A1—breast cancer	2.51e-06	2.69e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—NCOA3—breast cancer	2.5e-06	2.67e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CYP17A1—breast cancer	2.5e-06	2.67e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PIK3CB—breast cancer	2.49e-06	2.66e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PTGS1—breast cancer	2.49e-06	2.66e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ENO1—breast cancer	2.49e-06	2.66e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MAPK3—breast cancer	2.48e-06	2.66e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—SLC2A2—breast cancer	2.48e-06	2.65e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	2.48e-06	2.65e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—ENO1—breast cancer	2.47e-06	2.64e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PTGS1—breast cancer	2.47e-06	2.64e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PTGS2—breast cancer	2.47e-06	2.64e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	2.46e-06	2.63e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—ALB—breast cancer	2.45e-06	2.62e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CYP2D6—breast cancer	2.44e-06	2.61e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ABCG2—breast cancer	2.43e-06	2.6e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—MTR—breast cancer	2.43e-06	2.6e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CPT1A—breast cancer	2.43e-06	2.6e-05	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PIK3CA—breast cancer	2.42e-06	2.59e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CYP2D6—breast cancer	2.42e-06	2.59e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—RAF1—breast cancer	2.42e-06	2.58e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MYC—breast cancer	2.42e-06	2.58e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—TGFB1—breast cancer	2.41e-06	2.58e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—CAV1—breast cancer	2.4e-06	2.56e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—NCOA2—breast cancer	2.39e-06	2.56e-05	CbGpPWpGaD
Liotrix—TTR—Disease—AKT1—breast cancer	2.39e-06	2.56e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—HPGDS—breast cancer	2.38e-06	2.55e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—NCOA2—breast cancer	2.38e-06	2.55e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—HBA1—breast cancer	2.37e-06	2.53e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—EGFR—breast cancer	2.36e-06	2.53e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PIK3CB—breast cancer	2.36e-06	2.52e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—FASN—breast cancer	2.32e-06	2.48e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GSTT1—breast cancer	2.31e-06	2.47e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ACHE—breast cancer	2.31e-06	2.47e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—BCHE—breast cancer	2.31e-06	2.47e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—FASN—breast cancer	2.31e-06	2.47e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—BCHE—breast cancer	2.3e-06	2.46e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.29e-06	2.45e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—SLC5A5—breast cancer	2.28e-06	2.44e-05	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—AKT1—breast cancer	2.28e-06	2.44e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—SLC5A5—breast cancer	2.27e-06	2.43e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PIK3CD—breast cancer	2.24e-06	2.4e-05	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	2.24e-06	2.4e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—KRAS—breast cancer	2.23e-06	2.39e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—ALB—breast cancer	2.22e-06	2.37e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—NQO1—breast cancer	2.2e-06	2.36e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—SLC2A1—breast cancer	2.2e-06	2.36e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—NQO1—breast cancer	2.19e-06	2.35e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—SLC2A1—breast cancer	2.19e-06	2.35e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYP17A1—breast cancer	2.19e-06	2.34e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PIK3CG—breast cancer	2.18e-06	2.34e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PTGS1—breast cancer	2.17e-06	2.32e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ENO1—breast cancer	2.17e-06	2.32e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—IL2—breast cancer	2.17e-06	2.32e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.16e-06	2.31e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PTEN—breast cancer	2.15e-06	2.3e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CYP3A4—breast cancer	2.15e-06	2.3e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.15e-06	2.3e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.14e-06	2.29e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CYP3A4—breast cancer	2.14e-06	2.29e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.13e-06	2.28e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYP2D6—breast cancer	2.12e-06	2.27e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—NOS3—breast cancer	2.12e-06	2.27e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CYP1B1—breast cancer	2.11e-06	2.26e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CYP1B1—breast cancer	2.1e-06	2.25e-05	CbGpPWpGaD
Liotrix—ALB—Transmembrane transport of small molecules—RAF1—breast cancer	2.09e-06	2.24e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—NCOA2—breast cancer	2.08e-06	2.23e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—HSP90AA1—breast cancer	2.07e-06	2.22e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—HSP90AA1—breast cancer	2.06e-06	2.21e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—PIK3CA—breast cancer	2.05e-06	2.19e-05	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	2.03e-06	2.17e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—FASN—breast cancer	2.02e-06	2.16e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—NCOA1—breast cancer	2.02e-06	2.16e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—BCHE—breast cancer	2.01e-06	2.15e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—NCOA1—breast cancer	2.01e-06	2.15e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—SLC5A5—breast cancer	1.99e-06	2.13e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CYP19A1—breast cancer	1.99e-06	2.13e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—STK11—breast cancer	1.99e-06	2.13e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—TP53—breast cancer	1.98e-06	2.12e-05	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—AKT1—breast cancer	1.98e-06	2.12e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—STK11—breast cancer	1.98e-06	2.11e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CYP19A1—breast cancer	1.98e-06	2.11e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PIK3CB—breast cancer	1.96e-06	2.09e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PTGS2—breast cancer	1.94e-06	2.07e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—SLC2A1—breast cancer	1.92e-06	2.06e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—NQO1—breast cancer	1.92e-06	2.06e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PIK3CD—breast cancer	1.92e-06	2.05e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—HRAS—breast cancer	1.9e-06	2.03e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—ALB—breast cancer	1.9e-06	2.03e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—SRC—breast cancer	1.89e-06	2.02e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYP3A4—breast cancer	1.87e-06	2e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.87e-06	2e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.86e-06	1.98e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—COMT—breast cancer	1.85e-06	1.98e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYP1B1—breast cancer	1.84e-06	1.97e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—VEGFA—breast cancer	1.84e-06	1.97e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GSTP1—breast cancer	1.84e-06	1.97e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—COMT—breast cancer	1.84e-06	1.97e-05	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	1.83e-06	1.96e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—GSTP1—breast cancer	1.83e-06	1.96e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—IL6—breast cancer	1.82e-06	1.94e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—HMOX1—breast cancer	1.81e-06	1.94e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—NOS3—breast cancer	1.81e-06	1.94e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ITPR1—breast cancer	1.81e-06	1.94e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—HSP90AA1—breast cancer	1.81e-06	1.93e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—HMOX1—breast cancer	1.8e-06	1.93e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—ITPR1—breast cancer	1.8e-06	1.92e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—NCOA1—breast cancer	1.76e-06	1.88e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—MAPK3—breast cancer	1.74e-06	1.86e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ABCB1—breast cancer	1.74e-06	1.86e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—STK11—breast cancer	1.73e-06	1.85e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYP19A1—breast cancer	1.73e-06	1.85e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—ABCB1—breast cancer	1.73e-06	1.85e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—TYMS—breast cancer	1.71e-06	1.83e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—TYMS—breast cancer	1.7e-06	1.82e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PTEN—breast cancer	1.69e-06	1.81e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GSTM1—breast cancer	1.69e-06	1.81e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PLA2G4A—breast cancer	1.69e-06	1.81e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—NCOR1—breast cancer	1.69e-06	1.81e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—TGFB1—breast cancer	1.69e-06	1.81e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—GSTM1—breast cancer	1.68e-06	1.8e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—NCOR1—breast cancer	1.68e-06	1.8e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PLA2G4A—breast cancer	1.68e-06	1.8e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—AKT1—breast cancer	1.67e-06	1.79e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PIK3CB—breast cancer	1.67e-06	1.79e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PTGS2—breast cancer	1.66e-06	1.77e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GPX1—breast cancer	1.62e-06	1.73e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—COMT—breast cancer	1.61e-06	1.72e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—GPX1—breast cancer	1.61e-06	1.72e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GSTP1—breast cancer	1.6e-06	1.71e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CYP1A1—breast cancer	1.6e-06	1.71e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CYP1A1—breast cancer	1.59e-06	1.7e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ERCC2—breast cancer	1.59e-06	1.7e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—HMOX1—breast cancer	1.58e-06	1.69e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—ERCC2—breast cancer	1.58e-06	1.69e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ITPR1—breast cancer	1.58e-06	1.69e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—KRAS—breast cancer	1.56e-06	1.67e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PIK3CA—breast cancer	1.52e-06	1.62e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—MTHFR—breast cancer	1.49e-06	1.6e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—TYMS—breast cancer	1.49e-06	1.59e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—MTHFR—breast cancer	1.49e-06	1.59e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PLA2G4A—breast cancer	1.47e-06	1.58e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—NCOR1—breast cancer	1.47e-06	1.58e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GSTM1—breast cancer	1.47e-06	1.58e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PTEN—breast cancer	1.45e-06	1.55e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PIK3CA—breast cancer	1.44e-06	1.54e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GPX1—breast cancer	1.41e-06	1.51e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYP1A1—breast cancer	1.4e-06	1.49e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—TP53—breast cancer	1.39e-06	1.49e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ERCC2—breast cancer	1.38e-06	1.48e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CAV1—breast cancer	1.38e-06	1.47e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CAV1—breast cancer	1.37e-06	1.47e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—HRAS—breast cancer	1.33e-06	1.42e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.32e-06	1.41e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.31e-06	1.4e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—MTHFR—breast cancer	1.3e-06	1.39e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PIK3CG—breast cancer	1.25e-06	1.34e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PIK3CG—breast cancer	1.25e-06	1.33e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—AKT1—breast cancer	1.24e-06	1.33e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CAV1—breast cancer	1.2e-06	1.28e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PIK3CA—breast cancer	1.19e-06	1.28e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—AKT1—breast cancer	1.17e-06	1.26e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PIK3CD—breast cancer	1.1e-06	1.18e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PIK3CD—breast cancer	1.1e-06	1.17e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PIK3CG—breast cancer	1.09e-06	1.17e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ALB—breast cancer	1.09e-06	1.17e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—NOS3—breast cancer	1.04e-06	1.11e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—NOS3—breast cancer	1.04e-06	1.11e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PIK3CA—breast cancer	1.02e-06	1.09e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—AKT1—breast cancer	9.74e-07	1.04e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PIK3CB—breast cancer	9.62e-07	1.03e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PIK3CD—breast cancer	9.61e-07	1.03e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PIK3CB—breast cancer	9.56e-07	1.02e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PTGS2—breast cancer	9.53e-07	1.02e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ALB—breast cancer	9.49e-07	1.01e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PTGS2—breast cancer	9.47e-07	1.01e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—NOS3—breast cancer	9.08e-07	9.71e-06	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PIK3CB—breast cancer	8.38e-07	8.96e-06	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—AKT1—breast cancer	8.33e-07	8.92e-06	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PTEN—breast cancer	8.31e-07	8.89e-06	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PTGS2—breast cancer	8.3e-07	8.88e-06	CbGpPWpGaD
Liotrix—ALB—Metabolism—PTEN—breast cancer	8.26e-07	8.84e-06	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PTEN—breast cancer	7.24e-07	7.74e-06	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PIK3CA—breast cancer	5.86e-07	6.27e-06	CbGpPWpGaD
Liotrix—ALB—Metabolism—PIK3CA—breast cancer	5.83e-07	6.24e-06	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PIK3CA—breast cancer	5.11e-07	5.46e-06	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—AKT1—breast cancer	4.79e-07	5.12e-06	CbGpPWpGaD
Liotrix—ALB—Metabolism—AKT1—breast cancer	4.76e-07	5.09e-06	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—AKT1—breast cancer	4.17e-07	4.46e-06	CbGpPWpGaD
